Ubiquitin B pseudogene 3 (UBBP3)

Ubiquitin B pseudogene 3 (UBBP3) is one of several processed pseudogenes derived from the ubiquitin B gene (UBB) in humans[1]. Pseudogenes are genetic elements that share sequence similarity with known genes but carry mutations or genomic changes that prevent them from producing a functional protein[2]. UBBP3, like other processed UBB pseudogenes (UBBP1, UBBP2, UBBP5), originated from reverse-transcribed mRNA integration into the genome[1]. Unlike protein-coding genes, UBBP3 does not encode for an active ubiquitin protein, and there is no evidence for its transcriptional activity leading to a functional protein product[1][2]. It is not implicated directly as a disease gene, drug target, or biomarker, though, like other pseudogenes, it may serve as a source of noncoding RNA with potential regulatory effects yet to be fully understood. Currently, UBBP3's primary significance is as a genetic annotation in the human genome, aiding comparative genomics and evolutionary studies rather than therapeutic development[1][2].

Other names

Ubiquitin B pseudogene 3UBBP3